Antileukotriene Agents Versus Long‐Acting Beta‐Agonists in Older Adults with Persistent Asthma: A Comparison of Add‐On Therapies

To compare the effectiveness and cardiovascular safety of long‐acting beta‐agonists (LABAs) with those of leukotriene receptor antagonists (LTRAs) as add‐on treatments in older adults with asthma already taking inhaled corticosteroids (ICSs).

• Publication year

  2016

• Venue

  Journal of The American Geriatrics Society

• Publication date

  2016-06-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/jgs.14235PMID 27351988PMCID PMC7961814
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HEALTHCARE COST AND UTILIZATION PROJECT

  2017cited by this paper
• The Asthma-COPD Overlap Syndrome.

  2015cited by this paper
• Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.

  2014cited by this paper
• The Coexistence of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Prevalence and Risk Factors in Young, Middle-aged and Elderly People from the General Population

  2013cited by this paper
• Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients

  2013cited by this paper
• Montelukast as an Add-On Therapy to Inhaled Corticosteroids in the Treatment of Severe Asthma in Elderly Patients

  2012cited by this paper
• Is ‘GOLD’ standard for the management of COPD in clinical practice?

  2012cited by this paper
• Asthma in the elderly

  2012cited by this paper
• Doubly robust estimators of causal exposure effects with missing data in the outcome, exposure or a confounder

  2012cited by this paper
• Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease.

  2012cited by this paper
• Effect of age on asthma control: results from the National Asthma Survey.

  2011cited by this paper
• Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events.

  2010cited by this paper
• Quarterly Assessment of Short-Acting β2-Adrenergic Agonist Use as a Predictor of Subsequent Health Care Use for Asthmatic Patients in the United States

  2010cited by this paper
• Impact of asthma controller medications on medical and economic resource utilization in adult asthma patients

  2010cited by this paper
• An update on the safety of long-acting β-agonists in asthma patients using inhaled corticosteroids

  2010cited by this paper
• Direct costs of chronic obstructive pulmonary disease among managed care patients

  2010cited by this paper
• Asthma surveillance using Medicaid administrative data: a call for a national framework.

  2009cited by this paper
• Leukotriene Signaling in Atherosclerosis and Ischemia

  2009cited by this paper
• Safety of long-acting beta-agonists: urgent need to clear the air remains

  2009cited by this paper
• Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values.

  2009cited by this paper
• Risks of long-acting beta-agonists in achieving asthma control.

  2009cited by this paper
• Impact of asthma controller medications on clinical, economic, and patient-reported outcomes.

  2009cited by this paper
• Safety of long-acting β-agonists: urgent need to clear the air remains

  2009cited by this paper
• Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review

  2008cited by this paper
• Asthma costs and utilization in a managed care organization.

  2008cited by this paper
• An overview of cardiovascular disease burden in the United States.

  2007cited by this paper
• National surveillance for asthma--United States, 1980-2004.

  2007cited by this paper
• Rates of Hospitalizations and Emergency Department Visits in Patients with Asthma and Chronic Obstructive Pulmonary Disease Taking β‐Blockers

  2007cited by this paper
• Treating Asthma in the Older Patient

  2006cited by this paper
• Meta-Analysis: Effect of Long-Acting -Agonists on Severe Asthma Exacerbations and Asthma-Related Deaths

  2006cited by this paper
• External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?

  2006cited by this paper
• Overcoming Gaps in the Management of Asthma in Older Patients

  2005cited by this paper
• Summary health statistics for U.S. adults: National Health Interview Survey, 2001.

  2004cited by this paper
• Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis.

  2004cited by this paper
• The global burden of asthma: executive summary of the GINA Dissemination Committee Report

  2004cited by this paper
• Summary health statistics for U.S. adults: National Health Interview Survey, 2002.

  2004cited by this paper
• Serious asthma exacerbations in asthmatics treated with high-dose formoterol.

  2003cited by this paper
• Effects of montelukast and beclomethasone on airway function and asthma control.

  2002cited by this paper
• Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs.

  2002cited by this paper
• The Centers for Medicare and Medicaid Services.

  2001cited by this paper
• Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing.

  2001cited by this paper
• Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.

  2001cited by this paper
• Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT).

  2000cited by this paper
• Quality of Life and Economic Features in Elderly Asthmatics

  2000cited by this paper
• [Cardiovascular disease prevention in the elderly].

  2000cited by this paper
• Asthma in the elderly--a more severe disease.

  2000cited by this paper
• High heart rate: a risk factor for cardiovascular death in elderly men.

  1999cited by this paper
• GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

  1996cited by this paper
• GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

  1996cited by this paper
• Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research.

  1994cited by this paper
• Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research.

  1994cited by this paper
• of CE

  year unknowncited by this paper

• Consider the cardiovascular and pulmonary effects of treatments in patients with both asthma and cardiovascular disease

  2025cites this paper
• Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences

  2024cites this paper
• A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma.

  2021cites this paper
• Economic burden associated with receiving inhaled corticosteroids with either leukotriene receptor antagonists or long acting beta agonists as a combination therapy in older adults

  2021cites this paper
• Management of patients with asthma or COPD and cardiovascular disease: risks versus benefits

  2020cites this paper
• Economic Burden Associated with Receiving Inhaled Corticosteroids with Leukotriene Receptor Antagonists or Long-Acting Beta Agonists as Combination Therapy in Older Adults

  2018cites this paper